The National Institute of Child Health and Human Development (NICHD) awarded Giner Inc., a Boston-based research and development firm, a $312,817 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to develop a Point-of-Care Testing (POCT) device for highly sensitive and near-real-time measurement of oxytocin levels. The goal is to provide researchers and medical professionals with a simple, practical instrument that can accurately determine peripheral oxytocin levels, which are critical indicators during pregnancy, childbirth, and the postpartum period. The Phase I program will improve and validate Giner's existing electrochemical assay and build a pre-prototype POCT device featuring a disposable cartridge and handheld reader, with an assay time under 2 minutes. This research supports the NICHD's broader mission to explore fundamental biological mechanisms, clinical interventions, and translational research across maternal, child, and adolescent health domains.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $312.8k | 4/3/25 |